In this study, we investigated the mechanistic effects of metformin on RUNX2 and mTORC2 signaling pathways in breast cancer.<h4>Methods</h4>The study was conducted using in silico, in vitro, and in vivo analysis. Here, RUNX2 is linked to breast cancer.